Secondary Logo

Journal Logo

Articles by James A. Simon, MD

A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative

Lensen, Sarah; Archer, David; Bell, Robin J.; More

Menopause. 28(8):852-858, August 2021.

A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative

Lensen, Sarah; Bell, Robin J.; Carpenter, Janet S.; More

Menopause. 28(8):859-866, August 2021.

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Archer, David F.; Goldstein, Steven R.; Simon, James A.; More

Menopause. 26(6):611-621, June 2019.

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review

Simon, James A.; Goldstein, Irwin; Kim, Noel N.; More

Menopause. 25(7):837-847, July 2018.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy

Constantine, Ginger D.; Simon, James A.; Pickar, James H.; More

Menopause. 24(4):409-416, April 2017.

Show: